Jump to contents

Researcher Information

last modified：2024/01/08

Associate Professor　Hiroshi Arakawa

Mail

Faculty, Affiliation

Faculty of Pharmacy, Institute of Medical, Pharmaceutical and Health Sciences　Division of Pharmaceutical Sciences, Faculty of Pharmacy Institute of Medical, Pharmaceutical and Health Sciences
Assistant Professor

College and School Educational Field


Laboratory

Department of Membrane Transport of Biopharmaceutics,Laboratory of Molecular Pharmacotherapeutic, and Drug Metabolism and Toxicology

Academic Background

【Academic background(Doctoral/Master's Degree)】
Graduate School of Kanazawa University　Doctor　Graduate School of Natural Science and Technology　Divisions of Life Science　2013　Completed
【Academic background(Bachelor's Degree)】
Tokyo University of Science　Department of Pharmacy　2007
【Degree】
PhD

Career

Kanazawa University　Faculty of Pharmacy Institute of Medical, Pharmaceutical and Health Sciences　Assitant Professor(2016/02/01-)
Takasaki University of Health and Wealfare　Faculty of Pharmacy　Assitant Professor(2013/04/01-2016/01/31)

Year & Month of Birth

1983/04

Academic Society



Award









○4th APISSX Best Presentation Award, 1st Place (2011/04)

Specialities

Pharmacokinetics

Speciality Keywords

Pharmacokinetics

Research Themes

Drug Interaction via Renal Transporters

The Role of Drug Transporters on Drug Metabolism and Toxicity

Development of Novel Evaluation Systems for Pharmacokinetics

Alteration of Pharmacokinetics in Liver Dysfunction

Books

Papers

  • 　SLC35B1 significantly contributes to the uptake of UDPGA into the endoplasmic reticulum for glucuronidation catalyzed by UDP-glucuronosyltransferases　Ondo K, Arakawa H, Nakano M, Fukami T, Nakajima M　Biochem Pharmacol　2020/03/12
  • 　Aliphatic Oxaboroles Enabling Remarkable Recognition of Diols　Arakawa N, Nagao K, Murakami R, Sumida Y, Arakawa H, Inagaki F, Ohmiya H　Bull Chem Soc Jpn.　2020/02/26
  • 　Kinetic analysis of sequential metabolism of triazolam and its extrapolation to humans using an entero-hepatic two-organ microphysiological system　Arakawa H, Sugiura S, Kawanishi T, Shin K, Toyoda H, Satoh T, Sakai Y, Kanamori T, Kato Y　Lab Chip.　20　3　537-47　2020/01/13
  • 　Rat Kidney Slices for Evaluation of Apical Membrane Transporters in Proximal Tubular Cells　J Pharm Sci.　108　8　2798-804　2019/08
  • 　Bile Duct Obstruction Leads to Increased Intestinal Expression of Breast Cancer Resistance Protein With Reduced Gastrointestinal Absorption of Imatinib　Kawanishi T, Arakawa H, Masuo Y, Nakamichi N, Kato Y　J Pharm Sci.　108　9　3130-7　2019/05/14

show all

  • 　Uric acid analogue as a possible xenobiotic marker of uric acid transporter Urat1 in rats　Arakawa H, Amezawa N, Katsuyama T, Nakanishi T, Tamai I　Drug Metab Pharmacokinet.　34　2　155-8　2019/04
  • 　Evaluation of the metabolic capability of primary human hepatocytes in three-dimensional cultures on microstructural plates.　Koyama S, Arakawa H, Itoh M, Masuda N, Yano K, Kojima H, Ogihara T.　Biopharm Drug Dispos.　39　4　187-195　2018/04
  • 　Reduction Effect of Calcium Alginate on Blood Triglyceride Levels Causing the Inhibition of Hepatic and Total Body Accumulation of Fat in Rats　Kasahara F, Kato T, Idota Y, Takahashi H, Kakinuma C, Yano K, Arakawa H, Hara K, Miyajima C, Ogihara T　Biol Pharm Bull.　42　3　365-72　2019/05/01
  • 　Effect of tyrosine kinase inhibitors on renal handling of creatinine by MATE1.　Omote S, Matsuoka N, Arakawa H, Nakanishi T, Tamai I.　Sci Rep.　18　1　9237　2018/06/18
  • 　Organic Cation Transporter 1 Is Responsible for Hepatocellular Uptake of the Tyrosine Kinase Inhibitor Pazopanib　Ellawatty WEA, Masuo Y, Fujita KI, Yamazaki E, Ishida H, Arakawa H, Nakamichi N, Abdelwahed R, Sasaki Y, Kato Y.　Drug Metab Dispos.　46　1　33-40　2018
  • 　Inhibitory effect of crizotinib on creatinine uptake by renal secretory transporter OCT2.　Arakawa H, Omote S, Tamai I　Journal of Pharmaceutical Sciences　106　9　899-903　2017/03/13
  • 　Usefulness of kidney slices for functional analysis of apical reabsorptive transporters.　Arakawa H, Washio I, Matsuoka N, Kubo H, Staub AY, Nakamichi N, Ishiguro N, Kato Y, Nakanishi T, and Tamai I.　Sci. Rep.　7　1　12814　2017/10/09
  • 　Preliminary Evaluation of Three-Dimensional Primary Human Hepatocyte Culture System for Assay of Drug-Metabolizing Enzyme-Inducing Potential　Arakawa H, Kamioka H, Jomura T, Koyama S, Idota Y, Yano K, Kojima H, Ogihara T　Biol Pharm Bull.　40　7　967-74　2017/07
  • 　Different regulation of P-glycoprotein function between Caco-2 and Caki-1 cells by ezrin, radixin and moesin proteins.　Yano K, Otsuka K, Kato Y, Kawabata H, Ohmori S, Arakawa H, Ogihara T.　J Pharm Pharmacol.　68　3　361-7　2016/02/17
  • 　Cholesterol-Lowering Effect of Calcium Alginate in Rats.　Idota Y, Kogure Y, Kato T, Ogawa M, Kobayashi S, Kakinuma C, Yano K, Arakawa H, Miyajima C, Kasahara F, Ogihara T.　Biol Pharm Bull.　39　1　62-7　2016
  • 　Utility of human hepatocyte spheroids without feeder cells for evaluation of hepatotoxicity.　Ogihara T, Arakawa H, Jomura T, Idota Y, Koyama S, Yano K, Kojima H.　J. Toxicol. Sci.　42　599　2017
  • 　Possible interaction of quinolone antibiotics with peptide transporter 1 in oral absorption of peptide-mimetic drugs.　Arakawa H, Kamioka H, Kanagawa M, Hatano Y, Idota Y, Yano K, Morimoto K, Ogihara T.　Biopharm Drug Dispos.　37　1　39-45　2016
  • 　Interaction of Peptide Transporter 1 With D-Glucose and L-Glutamic Acid; Possible Involvement of Taste Receptors.　Arakawa H, Ohmachi T, Ichiba K, Kamioka H, Tomono T, Kanagawa M, Idota Y, Hatano Y, Yano K, Morimoto K, Ogihara T.　J Pharm Sci.　105　1　339-42　2016/01/13
  • 　Relationship between Physical Parameters of Various Metal Ions and Binding Affinity for Alginate　Idota Y, Kogure Y, Kato T, Yano K, Arakawa H, Miyajima C, Kasahara F, Ogihara T.　Biological and Pharmaceutical Bulletin　39　11　1893-1896　2016/07/26
  • 　Role of OATP2A1 in PGE(2) secretion from human colorectal cancer cells via exocytosis in response to oxidative stress　Kasai T, Nakanishi T, Ohno Y, Shimada H, Nakamura Y, Arakawa H, Tamai I.　Experimental Cell Research　341　2　123-131　2016/02/02
  • 　Utility of human hepatocyte spheroids for evaluation of hepatotoxicity.　Ogihara T, Iwai H, Inoue Y, Katagi J, Matsumoto N, Motoi-Ohtsuji M, Kakiki M, Kaneda S, Nagao T, Kusumoto K, Ozeki E, Jomura T, Tanaka S, Ueda T, Ohta T, Ohkura T, Arakawa H, Nagai D.　Fundam. Toxicol. Sci.　2　41　2015
  • 　Recommended Daily Dose of Sesame Lignans Has No Influence on Oral Absorption of P-Glycoprotein Substrates in Rats.　Tomono T, Otsuka K, Yano K, Kanagawa M, Arakawa H, Ogihara T.　Biol Pharm Bull.　38　12　1960-3　2015
  • 　Multiple Linear Regression Analysis Indicates Association of P-Glycoprotein Substrate or Inhibitor Character with Bitterness Intensity, Measured with a Sensor.　Yano K, Mita S, Morimoto K, Haraguchi T, Arakawa H, Yoshida M, Yamashita F, Uchida T, Ogihara T.　J Pharm Sci.　104　9　2789-94　2014/12/24
  • 　Evaluation of human hepatocytes cultured by three-dimensional spheroid systems for drug metabolism.　Ohkura T, Ohta K, Nagao T, Kusumoto K, Koeda A, Ueda T, Jomura T, Ikeya T, Ozeki E, Wada K, Naitoh K, Inoue Y, Takahashi N, Iwai H, Arakawa H, Ogihara T.　Drug Metab Pharmacokinet.　29　5　373-8　2014/04/01
  • 　Evaluation of a thiodipeptide, L-phenylalanyl-Ψ[CS-N]-L-alanine, as a novel probe for peptide transporter 1.　Arakawa H, Saito S, Kanagawa M, Kamioka H, Yano K, Morimoto K, Ogihara T.　Drug Metab Pharmacokinet.　29　6　470-4　2014
  • 　Characterization of cesium uptake mediated by a potassium transport system of bacteria in a soil conditioner.　Zhang P, Idota Y, Yano K, Negishi M, Kawabata H, Arakawa H, Morimoto K, Tsuji A, Ogihara T.　Biol Pharm Bull.　37　4　604-7　2014
  • 　Enhanced expression of organic anion transporting polypeptides (OATPs) in androgen receptor-positive prostate cancer cells: possible role of OATP1A2 in adaptive cell growth under androgen-depleted conditions.　Arakawa H, Nakanishi T, Yanagihara C, Nishimoto T, Wakayama T, Mizokami A, Namiki M, Kawai K, Tamai I.　Biochem Pharmacol　84　8　1070-7　2012/08/01
  • 　Active intestinal absorption of fluoroquinolone antibacterial agent ciprofloxacin by organic anion transporting polypeptide, Oatp1a5.　Arakawa H, Shirasaka Y, Haga M, Nakanishi T, Tamai I.　Biopharm Drug Dispos　33　6　332-41　2012/08/30
  • 　Impact of system L amino acid transporter 1 (LAT1) on proliferation of human ovarian cancer cells: a possible target for combination therapy with anti-proliferative aminopeptidase inhibitors.　Fan X, Ross DD, Arakawa H, Ganapathy V, Tamai I, Nakanishi T.　Biochem Pharmacol.　80　6　811-8　2010/05/26
  • 　Uptake transporter organic anion transporting polypeptide 1B3 contributes to the growth of estrogen-dependent breast cancer.　Maeda T, Irokawa M, Arakawa H, Kuraoka E, Nozawa T, Tateoka R, Itoh Y, Nakanishi T, Tamai I.　J Steroid Biochem Mol Biol.　122　4　180-5　2010/06/06
  • 　Involvement of organic anion transporting polypeptide 1a5 (Oatp1a5) in the intestinal absorption of endothelin receptor antagonist in rats.　Tani T, Gram LK, Arakawa H, Kikuchi A, Chiba M, Ishii Y, Steffansen B, Tamai I.　Pharm Res.　25　5　1085-91　2007/10/24

Conference Presentations

  • Utility of Three Dimensional Culture of Human Hepatocytes for Evaluation of Drug Metabolism Profile, Toxicity and Enzyme Induction.(conference：The 1st Workshop for Japan-Korea Young Scientists on Pharmaceutics.)(2016/07/24)

Others

Arts and Fieldwork

Patent

Theme to the desired joint research

Grant-in-Aid for Scientific Research

○「核磁気共鳴法を利用したペプチドトランスポーター標的型がん診断プローブの創出」(2016-2018)　

Competitive research funding,Contribution

Collaborative research,Consignment study

Classes (Bachelors)

Classes (Graduate Schools)

International Project

International Students

Lecture themes

Others (Social Activities)

To Page Top